185 related articles for article (PubMed ID: 32873131)
21. BIOLUX P-III Passeo-18 Lux All-Comers Registry: 24-Month Results in Below-the-Knee Arteries.
Tepe G; Wang J; Corpataux JM; Pua U; Binkert CA; Moscovic M; Ghotbi R; Keirse K; Robertson D; Brodmann M
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):10-18. PubMed ID: 32964317
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
23. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
24. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
25. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
26. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
Wei L; Guo J; Guo L; Qi L; Cui S; Tong Z; Hou P; Gu Y
Vasa; 2022 Sep; 51(5):275-281. PubMed ID: 35801303
[No Abstract] [Full Text] [Related]
27. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
[TBL] [Abstract][Full Text] [Related]
28. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
29. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
[TBL] [Abstract][Full Text] [Related]
30. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; von Flotow P; Heilmeier B; Sixt S; Brucks S; Erbel C; Beschorner U; Werk M; Riambau V; Wienke A; Klumb CT; Thieme M
Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
[TBL] [Abstract][Full Text] [Related]
31. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
Teymen B; Akturk S; Akturk U; Tdjani M
Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
[TBL] [Abstract][Full Text] [Related]
32. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease.
Shishehbor MH; Scheinert D; Jain A; Brodmann M; Tepe G; Ando K; Krishnan P; Iida O; Laird JR; Schneider PA; Rocha-Singh KJ; Zeller T
J Am Coll Cardiol; 2023 Jan; 81(3):237-249. PubMed ID: 36332764
[TBL] [Abstract][Full Text] [Related]
34. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
Bausback Y; Wittig T; Schmidt A; Zeller T; Bosiers M; Peeters P; Brucks S; Lottes AE; Scheinert D; Steiner S
J Am Coll Cardiol; 2019 Feb; 73(6):667-679. PubMed ID: 30765033
[TBL] [Abstract][Full Text] [Related]
35. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
36. Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
Deloose KR; Lansink W; Brodmann M; Werner M; Keirse K; Gouëffic Y; Verbist J; Maene L; Hendriks JMH; Brunet J; Ducasse E; Levent K; Sauguet A; Vandael F; Vercauteren S; Callaert J
JACC Cardiovasc Interv; 2023 Dec; 16(23):2900-2914. PubMed ID: 38092496
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of Stented vs Nonstented Femoropopliteal Lesions Treated With Drug-Coated Balloon Angioplasty.
Giannopoulos S; Strobel A; Rudofker E; Kovach C; Kokkosis AA; Armstrong EJ
J Endovasc Ther; 2023 Apr; 30(2):194-203. PubMed ID: 35179065
[TBL] [Abstract][Full Text] [Related]
38. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
39. Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial.
Iida O; Urasawa K; Komura Y; Soga Y; Inoue N; Hara H; Yajima J; Nakamura S; Ohki T; Ando H; Hirano K; Horita Y; Kichikawa K; Yokoi Y; Miyamoto A; Nakamura M; Takahara M; Mano T; Nanto S
J Endovasc Ther; 2019 Apr; 26(2):158-167. PubMed ID: 30702021
[TBL] [Abstract][Full Text] [Related]
40. Real-World Experience With a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III.
Brodmann M; Moscovic M; Wang JCC; Nano G; Dahm J; Zeller T; Christensen JK; Keirse K; Ghotbi R; Corpataux JM; Tepe G
JACC Cardiovasc Interv; 2020 Oct; 13(19):2289-2299. PubMed ID: 32950415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
